Pharmacotherapy Of Alzheimers Disease
Download Pharmacotherapy Of Alzheimers Disease full books in PDF, epub, and Kindle. Read online free Pharmacotherapy Of Alzheimers Disease ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Barbara G. Wells |
| Publisher | : McGraw Hill Professional |
| Total Pages | : 1066 |
| Release | : 2009-01-14 |
| Genre | : Medical |
| ISBN | : 0071643265 |
Essential Pharmacotherapy Data at Your Fingertips! A Doody's Core Title ESSENTIAL PURCHASE! 4 STAR DOODY'S REVIEW "The book addresses all aspects of 84 disease states and disorders, from presentation and pathology to treatment and monitoring. Each chapter focuses on individual groups of medication considered for treatment and gives a concise overview of them in easy to see bulleted points. The qualities that I find especially useful are that charts and algorithms are easily identifiable and tables are shaded light gray for quick reference . . . Although this handbook contains an enormous amount of information, it conveniently fits into a lab coat pocket. It is an extremely useful reference." -- Doody's Pharmacotherapy Handbook delivers the essential information you need to quickly and confidently make drug therapy decisions for eighty-four diseases and disorders. Featuring a convenient alphabetized presentation, the book utilizes text, tables, figures, and treatment algorithms to make important drug data readily accessible and easily understandable. Features: Consistent chapter organization that includes: Disease state definition, Concise review of relevant pathophysiology, Clinical presentation, Diagnosis, Desired outcome, Treatment, Monitoring Six valuable appendices, including a new one on the management of pharmacotherapy in the elderly NEW chapters on adrenal gland disorders and influenza The ideal companion to Pharmacology: A Pathophysiologic Approach, 7e by Joseph DiPiro et al.
| Author | : Serge Gauthier |
| Publisher | : CRC Press |
| Total Pages | : 188 |
| Release | : 1998-01-01 |
| Genre | : Medical |
| ISBN | : 9781853175831 |
This thorough guide details clinical trials, the drugs currently available and the expectations of the doctor, family and carer
| Author | : Atta-ur Rahman |
| Publisher | : Elsevier |
| Total Pages | : 785 |
| Release | : 2015-06-27 |
| Genre | : Medical |
| ISBN | : 0128039604 |
Drug Design and Discovery in Alzheimer's Disease includes expert reviews of recent developments in Alzheimer's disease (AD) and neurodegenerative disease research. Originally published by Bentham as Frontiers in Drug Design and Discovery, Volume 6and now distributed by Elsevier, this compilation of the sixteen articles, written by leading global researchers, focuses on key developments in the understanding of the disease at molecular levels, identification and validation of molecular targets, as well as innovative approaches towards drug discovery, development, and delivery. Beginning with an overview of AD pharmacotherapy and existing blockbuster drugs, the reviews cover the potential of both natural and synthetic small molecules; the role of cholinesterases in the on-set and progression of AD and their inhibition; the role of beta-site APP clearing enzyme-1 (BACE-1) in the production of ß-amyloid proteins, one of the key reasons of the progression of AD; and other targets identified for AD drug discovery. - Edited and written by leading experts in Alzheimer's disease (AD) and other neurodegenerative disease drug development - Describes existing drugs for AD and current molecular understanding of the condition - Reviews recent advances in the field, including coverage of cholinesterases, BACE-1, and other drug development targets
| Author | : Adeboye Adejare |
| Publisher | : Academic Press |
| Total Pages | : 310 |
| Release | : 2016-09-20 |
| Genre | : Medical |
| ISBN | : 0128028114 |
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease examines the drug discovery process for neurodegenerative diseases by focusing specifically on Alzheimer's Disease and illustrating the paradigm necessary to ensure future research and treatment success. The book explores diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more to provide a holistic approach to the discovery, development, and treatment of Alzheimer's Disease. Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. It illustrates why these drugs tend to fail at the clinical stage, and examines Alzheimer's Disease within the overall context of improving the drug discovery process for the treatment of other neurodegenerative disorders. - Provides a compilation of chemical considerations required in drug discovery for the treatment of neurodegenerative disorders - Examines different classes of compounds currently being used in discovery and development stages - Explores in vitro and in vivo models with respect to their ability to translate these models to human conditions - Distills the most significant information across multiple areas of Alzheimer's disease research to provide a single, comprehensive, and balanced resource
| Author | : Gustavo Alves Andrade dos Santos |
| Publisher | : Springer Nature |
| Total Pages | : 239 |
| Release | : 2022-03-25 |
| Genre | : Medical |
| ISBN | : 3030943836 |
Alzheimer’s disease is the most prevalent form of dementia. Although it was discovered about a century ago, the first drugs applied in treatment were only introduced in therapy in the last 30 years. This book focuses on the clinical pharmacology of drugs that aim to delay the progression of Alzheimer’s disease, such as anticholinesterases and glutamate receptor antagonists, as well as treatment for the behavioral changes caused by the progression of the disease: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. In addition, it describes important information about the pathophysiology and diagnostic methods of Alzheimer’s disease, emergency situations conditioned by the dementia process, and presents new perspectives for the treatment of Alzheimer’s disease. The ten chapters cover topics such as mechanism of action, dosage regimen, adverse reactions, drug interactions, toxicity profiles, among other information of clinical relevance. The work comprises evidence-based studies, providing a valuable resource for analyzing, prescribing and monitoring patients being treated for Alzheimer’s disease. Written by experts with solid professional experience, this book will appeal to pharmacologists, geriatricians, neurologists, psychiatrists, biomedical clinicians, and other healthcare professionals.
| Author | : Alan J. Sinclair |
| Publisher | : John Wiley & Sons |
| Total Pages | : 3453 |
| Release | : 2012-03-13 |
| Genre | : Medical |
| ISBN | : 1119954142 |
This new edition of the comprehensive and renowned textbook Principles and Practice of Geriatric Medicine offers a fully revised and updated review of geriatric medicine. It covers the full spectrum of the subject, features 41 new chapters, and provides up-to-date, evidence-based, and practical information about the varied medical problems of ageing citizens. The three editors, from UK, USA and France, have ensured that updated chapters provide a global perspective of geriatric medicine, as well as reflect the changes in treatment options and medical conditions which have emerged since publication of the 4th edition in 2006. The book includes expanded sections on acute stroke, dementia, cardiovascular disease, and respiratory diseases, and features a new section on end-of-life care. In the tradition of previous editions, this all-encompassing text continues to be a must-have text for all clinicians who deal with older people, particularly geriatric medical specialists, gerontologists, researchers, and general practitioners. This title is also available as a mobile App from MedHand Mobile Libraries. Buy it now from Google Play or the MedHand Store. Praise for the 4th edition: "...an excellent reference for learners at all clinical and preclinical levels and a useful contribution to the geriatric medical literature." —Journal of the American Medical Association, November 2006 5th edition selected for 2012 Edition of Doody's Core TitlesTM
| Author | : Takashi Kudo |
| Publisher | : Springer |
| Total Pages | : 144 |
| Release | : 2016-02-10 |
| Genre | : Medical |
| ISBN | : 3319262068 |
In this book, the four leading experts on the ACE inhibitors donepezil, galantamine, and rivastigmine and the NMDA receptor antagonist memantine explain the practical pharmacology of these symptomatic drugs with the aim of providing a sound basis for their clinical use in patients with Alzheimer’s disease. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer’s disease and the book closes with an overview of the ways in which symptomatic drugs for dementia are used. The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer’s disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. The failure of clinical trials of these drugs to yield satisfactory results has, however, meant that for the time being patients continue to be treated only with symptomatic drugs. There is accordingly a need to become more proficient in the use of symptomatic medicines, and it is against the background of this quest that Practical Pharmacology for Alzheimer’s Disease will be of wide interest.
| Author | : Panayiotis Vlamos |
| Publisher | : Springer Nature |
| Total Pages | : 154 |
| Release | : 2020-05-28 |
| Genre | : Medical |
| ISBN | : 3030326373 |
The 3rd World Congress on Genetics, Geriatrics, and Neurodegenerative Disease Research (GeNeDis 2018), focuses on recent advances in genetics, geriatrics, and neurodegeneration, ranging from basic science to clinical and pharmaceutical developments. It also provides an international forum for the latest scientific discoveries, medical practices, and care initiatives. Advanced information technologies are discussed, including the basic research, implementation of medico-social policies, and the European and global issues in the funding of long-term care for elderly people.
| Author | : Jeffrey Cummings |
| Publisher | : Cambridge University Press |
| Total Pages | : 575 |
| Release | : 2022-03-31 |
| Genre | : Business & Economics |
| ISBN | : 1108838669 |
Provides a definitive overview of the complex ecosystem facilitating Alzheimer's Disease drug research and development. Demonstrates a drug's journey from in the lab, clinical trial testing, regulatory review, and marketing by pharmaceutical companies. Details the use of artificial intelligence, clinical trial management, and financing models.
| Author | : American Psychiatric Association |
| Publisher | : American Psychiatric Pub |
| Total Pages | : 220 |
| Release | : 2016 |
| Genre | : Medical |
| ISBN | : 0890426775 |
The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms.
